[NUVA] NuVasive, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 66.29 Change: 0.51 (0.78%)
Ext. hours: Change: 0 (0%)

chart NUVA

Refresh chart

Strongest Trends Summary For NUVA

NUVA is in the medium-term up 30% in 2 months and down -17% in 7 months. In the long-term up 166% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company?s principal product offering includes a minimally disruptive surgical platform, known Maximum Access Surgery (MAS) that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) support; MaXcess, an integrated split-blade retractor system; and various specialized implants. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company?s biologic product line offerings used to aid the spinal fusion process or bone healing consist of allograft (donated human tissue); Osteocel Plus, an allograft cellular matrix containing via

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 6.84% Sales Growth - Q/Q5.47% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA3.69% ROE7.11% ROI4.18%
Current Ratio5.17 Quick Ratio3.93 Long Term Debt/Equity0.67 Debt Ratio0.2
Gross Margin76.15% Operating Margin15.49% Net Profit Margin6.01% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-26.25 M Cash From Investing Activities-72.14 M Cash From Operating Activities35.18 M Gross Profit154.5 M
Net Profit10.27 M Operating Profit25.86 M Total Assets1.29 B Total Current Assets684.33 M
Total Current Liabilities132.44 M Total Debt368.5 M Total Liabilities618.32 M Total Revenue202.91 M
Technical Data
High 52 week71.41 Low 52 week44.53 Last close58.1 Last change-0.45%
RSI70.47 Average true range2.46 Beta1 Volume185.56 K
Simple moving average 20 days8.32% Simple moving average 50 days14.45% Simple moving average 200 days0.25%
Performance Data
Performance Week-0.84% Performance Month18.98% Performance Quart-5.53% Performance Half-17.34%
Performance Year23.67% Performance Year-to-date17.23% Volatility daily3.21% Volatility weekly7.18%
Volatility monthly14.71% Volatility yearly50.95% Relative Volume231.69% Average Volume804.48 K
New High New Low

News

2019-03-22 09:30:01 | NuVasive NUVA Down 1% Since Last Earnings Report: Can It Rebound?

2019-03-12 15:30:51 | Options Bears Jump on Battered NuVasive Stock

2019-03-12 10:31:46 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-03-06 16:05:00 | NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019

2019-03-06 13:39:00 | Why NuVasive Stock Rose 18% in February

2019-03-06 07:55:00 | Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2019-03-05 16:05:00 | NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference

2019-02-22 07:50:12 | NuVasive NUVA Q4 Earnings Beat Estimates, Margins Fall

2019-02-21 16:05:00 | NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference

2019-02-21 14:17:47 | NuVasive NUVA Q4 2018 Earnings Conference Call Transcript

2019-02-21 05:58:03 | Edited Transcript of NUVA earnings conference call or presentation 20-Feb-19 9:30pm GMT

2019-02-20 18:21:00 | NuVasive Overcomes Industry Headwinds to Finish 2018 Strong

2019-02-20 17:40:10 | NuVasive NUVA Q4 Earnings and Revenues Top Estimates

2019-02-20 16:34:26 | NuVasive: 4Q Earnings Snapshot

2019-02-20 16:02:00 | NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results

2019-02-20 14:30:00 | NuVasive, Inc. to Host Earnings Call

2019-02-19 08:30:00 | NuVasive's Proprietary Magnetic Implant System To Be Used In First-Of-Its-Kind, All-Internal Bone Transport System

2019-02-13 10:31:03 | NuVasive NUVA Earnings Expected to Grow: Should You Buy?

2019-02-13 07:50:00 | New Research: Key Drivers of Growth for Plains Group Holdings, Cooper Tire & Rubber, NuVasive, Envestnet, Pacific Ethanol, and Mistras Group — Factors of Influence, Major Initiatives and Sustained Production

2019-02-12 10:21:33 | Jefferies Downgrades NuVasive, Says M&A Unlikely To Materialize

2019-02-12 00:00:24 | [$$] Morgan Stanley tests M&A waters with millennial millionaires play

2019-02-11 16:34:00 | Why NuVasive, Avis Budget Group, and Insperity Jumped Today

2019-02-11 16:20:00 | NuVasive Stock Surges on Report of Smith & Nephew Interest

2019-02-11 16:17:39 | Medical Stock Pops On Potential $3 Billion Smith & Nephew Takeover

2019-02-11 13:33:39 | Here’s why NuVasive, Inc.’s NASDAQ:NUVA Returns On Capital Matters So Much

2019-02-11 11:44:21 | NuVasive Stock Shoots Higher on Takeover Talk

2019-02-11 10:45:00 | Here's Why NuVasive Stock Is Soaring Today

2019-02-11 09:58:09 | Smith & Nephew Drops on Report of Deal Talks With NuVasive

2019-02-11 09:00:00 | Alphatec Announces Stay of Court Proceedings in NuVasive Patent Lawsuit

2019-02-11 06:37:00 | Trade Talks, Shutdown, NuVasive, Activision, Amazon - 5 Things You Must Know

2019-02-08 20:57:58 | Smith & Nephew in talks to buy NuVasive for over $3 billion - FT

2019-02-08 20:52:22 | Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

2019-02-08 08:06:19 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-02-08 04:10:22 | [$$] Smith & Nephew in talks to buy NuVasive for over $3bn

2019-01-29 16:05:00 | NuVasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2018 Results

2019-01-29 08:05:49 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-01-15 08:06:15 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-01-11 12:24:19 | Tamarack Capital Management’s Return, AUM, and Holdings

2019-01-10 08:12:12 | Did NuVasive, Inc. NASDAQ:NUVA Insiders Buy Up More Shares?

2019-01-10 08:03:02 | Why Globus Medical Stock Rose 10% on January 9

2019-01-09 08:06:55 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-01-07 17:20:00 | Stocks making the biggest moves after hours: Union Pacific, Lennar and more

2019-01-07 08:30:00 | NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results

2019-01-03 09:07:02 | Solid Global Business Aids NuVasive Amid Pricing Pressure

2019-01-03 08:30:00 | NuVasive CEO J. Christopher Barry Announces New Organizational Structure And Leadership Team

2018-12-27 16:05:00 | NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference

2018-12-21 08:06:15 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-20 08:06:44 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-19 18:24:59 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-14 03:32:17 | NuVasive, Inc. NUVA: Are Hedge Funds Right About This Stock?